Results 1 -
10
of
37
for
IBRUTINIB
- Ibrutinib is used: to treat people with mantle cell lymphoma (MCL; a fast-growing cancer that begins ... being treated unsuccessfully with 1 or more medications. Ibrutinib is in a class of medications called kinase ...
- ... Several PLCG2 gene mutations have been associated with ibrutinib resistance, which is a condition in which the drug ibrutinib becomes ineffective in people with these mutations. Ibrutinib ...
- Acute Lymphocytic Leukemia/Statistics and Research ... Acute Lymphocytic Leukemia ... Childhood Leukemia/Statistics and Research ... Childhood Leukemia ... Leukemia/Statistics ...
- What's New in Non-Hodgkin Lymphoma Research and Treatment? (American Cancer Society)Lymphoma/Statistics and Research ... Lymphoma ... Research into the causes, prevention, and treatment of non-Hodgkin lymphoma is being done in many medical centers ...
- ... activates AKT and ERK, and promotes resistance to ibrutinib and other agents used in the treatment of ... CXCR4 WHIM-like frameshift and nonsense mutations promote ibrutinib resistance but do not supplant MYD88(L265P) -directed ...
- Chronic lymphocytic leukemia (CLL) treatment can include observation, steroids, radiation therapy, chemotherapy, surgery, or targeted therapy. Learn more ...
- Primary central nervous system (CNS) lymphoma treatment options include radiation, chemotherapy, targeted therapy, and corticosteroids. Learn more about ...
- Non-Hodgkin lymphoma (NHL) options include chemotherapy, radiation, targeted therapy, plasmapheresis, surveillance, stem cell transplant, and surgery. ...
- Lymphoma/Treatments and Therapies ... Lymphoma ... National Cancer Institute ... Primary central nervous system (CNS) lymphoma treatment options include radiation, chemotherapy, ...
- Chronic Lymphocytic Leukemia/Treatments and Therapies ... Chronic Lymphocytic Leukemia ... National Cancer Institute ... Chronic lymphocytic leukemia (CLL) treatment ...